CIVCO Medical Solutions Announces Facilities Relocation

April 13, 2023 |

CIVCO’s Coralville corporate & Kalona manufacturing facilities will move to a new, combined space in Coralville area


Coralville, IA (March 21, 2023) CIVCO Medical Solutions, a leading manufacturer of ultrasound infection control, high-level disinfection, and needle guidance devices, will move into a new corporate and manufacturing facility in the Iowa City/Coralville area, with estimated occupancy in 2025. CIVCO’s current corporate headquarters is based on Jones Boulevard in Coralville and its Iowa-based manufacturing facility is in Kalona.


The consolidated facility will allow for CIVCO’s continued growth in operational and corporate hiring as the company develops and commercializes new medical device products that advance the safety of ultrasound.


“We are excited to bring our manufacturing and corporate functions together under one roof in Coralville,” said Robin Therme, CIVCO President. “These changes will allow for improved logistics and capabilities, while also supporting our current growth and what we anticipate in the future.”


No workforce reductions will occur as a result of the facility relocation.



CIVCO Medical Solutions has over 40 years of experience making ultrasound-guided procedures safer. CIVCO designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures with a strong focus on ultrasound. CIVCO’s specialties include infection control, high-level disinfection of ultrasound probes, needle and device guidance, electromagnetic needle tracking, and transperineal prostate solutions. Corporate information is available at

CIVCO operates as a unit of Roper Technologies. Roper Technologies is a constituent of the S&P 500 and Fortune 500. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess free cash flow toward high-quality acquisitions. Additional information about Roper is available on the Company’s website at


# # #

For more information, please contact:

Erin DoughertyCIVCO Medical SolutionsTel: